CAINDEXNAME:GUANIDINE,[(3-IODOPHENYL)METHYL]
![CAINDEXNAME:GUANIDINE,[(3-IODOPHENYL)METHYL] Structure](https://image.chemsrc.com/caspic/215/80663-95-2.png)
CAINDEXNAME:GUANIDINE,[(3-IODOPHENYL)METHYL] structure
|
Common Name | CAINDEXNAME:GUANIDINE,[(3-IODOPHENYL)METHYL] | ||
|---|---|---|---|---|
| CAS Number | 80663-95-2 | Molecular Weight | 648.25800 | |
| Density | 1.85g/cm3 | Boiling Point | 382.1ºC at 760mmHg | |
| Molecular Formula | C16H22I2N6O4S | Melting Point | N/A | |
| MSDS | USA | Flash Point | 184.9ºC | |
| Name | 3-Iodobenzyl-guanidine hemisulfate |
|---|---|
| Synonym | More Synonyms |
| Density | 1.85g/cm3 |
|---|---|
| Boiling Point | 382.1ºC at 760mmHg |
| Molecular Formula | C16H22I2N6O4S |
| Molecular Weight | 648.25800 |
| Flash Point | 184.9ºC |
| Exact Mass | 647.95100 |
| PSA | 206.78000 |
| LogP | 5.35840 |
| Storage condition | 2-8°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 29252900 |
|
~40%
CAINDEXNAME:GUA... CAS#:80663-95-2 |
| Literature: Wieland; Donald M.; Brown; Lawrence E.; Beierwaltes; William H.; Wu; Jiann-long Patent: US4584187 A1, 1986 ; |
|
~%
CAINDEXNAME:GUA... CAS#:80663-95-2 |
| Literature: Gourand, Fabienne; Mercey, Guillaume; Ibazizene, Meziane; Tirel, Olivier; Henry, Joel; Levacher, Vincent; Perrio, Cecile; Barre, Louisa Journal of Medicinal Chemistry, 2010 , vol. 53, # 3 p. 1281 - 1287 |
|
~%
CAINDEXNAME:GUA... CAS#:80663-95-2 |
| Literature: Wieland; Mangner; Inbasekaran; Brown; Wu Journal of Medicinal Chemistry, 1984 , vol. 27, # 2 p. 149 - 155 |
|
~40%
CAINDEXNAME:GUA... CAS#:80663-95-2 |
| Literature: Wilson, Lawrence J.; Klopfenstein, Sean R.; Li, Min Tetrahedron Letters, 1999 , vol. 40, # 21 p. 3999 - 4002 |
|
Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65.
Sci. Signal. 7(351) , ra106, (2014) Inflammation increases the abundance of inducible nitric oxide synthase (iNOS), leading to enhanced production of nitric oxide (NO), which can modify proteins by S-nitrosylation. Enhanced NO productio... |
|
|
The effects of MIBG on the invasive properties of HepG2 hepatocellular carcinoma cells.
Int. J. Mol. Med. 34(3) , 842-8, (2014) The aim of the present study was to investigate the effects of meta-iodobenzylguanidine (MIBG) on the invasive properties of hepatocellular carcinoma (HCC) cells and examine whether these effects are ... |
|
|
Patient-specific dosimetry using pretherapy [¹²⁴I]m-iodobenzylguanidine ([¹²⁴I]mIBG) dynamic PET/CT imaging before [¹³¹I]mIBG targeted radionuclide therapy for neuroblastoma.
Mol. Imaging Biol. 17(2) , 284-94, (2015) Iodine-131-m-iodobenzylguanidine ([(131)I]mIBG)-targeted radionuclide therapy (TRT) is a standard treatment for recurrent or refractory neuroblastoma with response rates of 30-40 %. The aim of this st... |
| meta-iodobenzylguanidine |
| 3-iodo benzyl guanidine |
| m-Iod-6-benzylaminopurin |
| N-Dimethylhomotryptamin |
| N-Dimethylhomotryptamine |
| MFCD00151189 |